Item | Staged group | Regular group | t value | P |
---|---|---|---|---|
pre-Reh | ||||
VAS | 2.84 ± 0.69 | 3.00 ± 0.75 | --0.794 | 0.431 |
JOA | 17.28 ± 1.59 | 17.81 ± 1.52 | -1.208 | 0.233 |
Oswestry | 21.56 ± 5.27 | 23.73.90 ± 5.23 | -1.477 | 0.146 |
SF-36 | 510.08 ± 59.71 | 523.27 ± 57.38 | -0.804 | 0.425 |
6 weeks post-Reh (1st stage) | ||||
VAS | 1.96 ± 0.68a | 2.42 ± 0.78a | -2.300 | 0.026 |
JOA | 20.84 ± 2.19a | 19.61 ± 1.88a | 2.145 | 0.037 |
Oswestry | 18.28 ± 4.70a | 21.46 ± 4.82 | -2.385 | 0.021 |
SF-36 | 633.52 ± 52.41a | 598.31 ± 67.64a | 2.072 | 0.044 |
12 weeks post-Reh (2nd stage) | ||||
VAS | 1.08 ± 0.40a | 1.38 ± 0.70a | -1.903 | 0.063 |
JOA | 23.88 ± 2.43a | 22.88 ± 2.86a | 1.335 | 0.188 |
Oswestry | 14.68 ± 2.86a | 17.38 ± 3.15a | -3.202 | 0.002 |
SF-36 | 721.52 ± 55.74a | 668.11 ± 71.38a | 2.970 | 0.005 |
24 weeks post-Reh (3rd stage) | ||||
VAS | 0.48 ± 0.51a | 0.69 ± 0.55a | -1.429 | 0.159 |
JOA | 27.88 ± 1.17a | 27.46 ± 1.21a | 1.258 | 0.214 |
Oswestry | 11.48 ± 1.26a | 11.38 ± 0.85a | 0.317 | 0.752 |
SF-36 | 775.80 ± 55.48a | 746.54 ± 40.69a | 2.154 | 0.036 |